Literature DB >> 33987125

Delayed-onset Necrotizing Myositis following COVID-19 Infection.

Sravani Lokineni1, Mahta Mortezavi2.   

Abstract

As the numbers of cases of COVID-19 continue to rise, the heterogeneity of its clinical manifestation continues to increase. Here, we describe a case of delayed-onset, biopsy-proven necrotizing myositis following infection with SARS-CoV-2. LEARNING POINTS: SARS-CoV-2 may be associated with late-onset necrotizing myositis, mimicking autoimmune inflammatory myositis.We need more studies to understand the underlying pathogenesis of SARS-CoV-2-induced myositis. © EFIM 2021.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; necrotizing autoimmune myositis

Year:  2021        PMID： 33987125      PMCID： PMC8112084          DOI： 10.12890/2021_002461

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN： 2284-2594


  6 in total

Review 1.  Inflammatory muscle diseases.

Authors:  Marinos C Dalakas
Journal:  N Engl J Med       Date:  2015-04-30       Impact factor: 91.245

Review 2.  Triggers of inflammatory myopathy: insights into pathogenesis.

Authors:  Brittany L Adler; Lisa Christopher-Stine
Journal:  Discov Med       Date:  2018-02       Impact factor: 2.970

3.  Myositis as a manifestation of SARS-CoV-2.

Authors:  Maxime Beydon; Kevin Chevalier; Omar Al Tabaa; Sabrina Hamroun; Anne-Sophie Delettre; Marion Thomas; Julia Herrou; Elodie Riviere; Xavier Mariette
Journal:  Ann Rheum Dis       Date:  2020-04-23       Impact factor: 19.103

4.  COVID-19-associated myositis with severe proximal and bulbar weakness.

Authors:  Hui Zhang; Zeinab Charmchi; Roberta J Seidman; Yaacov Anziska; Vinodkumar Velayudhan; Jonathan Perk
Journal:  Muscle Nerve       Date:  2020-07-03       Impact factor: 3.852

Review 5.  Neuromuscular presentations in patients with COVID-19.

Authors:  Vimal Kumar Paliwal; Ravindra Kumar Garg; Ankit Gupta; Nidhi Tejan
Journal:  Neurol Sci       Date:  2020-09-15       Impact factor: 3.307

6.  Covid-19-Associated Myopathy Caused by Type I Interferonopathy.

Authors:  Giovanna S Manzano; Jared K Woods; Anthony A Amato
Journal:  N Engl J Med       Date:  2020-11-20       Impact factor: 91.245
  6 in total
  3 in total

Review 1.  From the Ketogenic Diet to the Mediterranean Diet: The Potential Dietary Therapy in Patients with Obesity after CoVID-19 Infection (Post CoVID Syndrome).

Authors:  Luigi Barrea; Claudia Vetrani; Massimiliano Caprio; Mauro Cataldi; Marwan El Ghoch; Ausilia Elce; Elisabetta Camajani; Ludovica Verde; Silvia Savastano; Annamaria Colao; Giovanna Muscogiuri
Journal:  Curr Obes Rep       Date:  2022-05-06

Review 2.  Rheumatological complications of Covid 19.

Authors:  Hannah Zacharias; Shirish Dubey; Gouri Koduri; David D'Cruz
Journal:  Autoimmun Rev       Date:  2021-07-05       Impact factor: 9.754

Review 3.  New Onset of Autoimmune Diseases Following COVID-19 Diagnosis.

Authors:  Abraham Edgar Gracia-Ramos; Eduardo Martin-Nares; Gabriela Hernández-Molina
Journal:  Cells       Date:  2021-12-20       Impact factor: 6.600
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.